 |
FDA Public Workshop on Clinical Trial Endpoints in Colorectal Cancer
The Food and Drug Administration (FDA) is holding a public
workshop on endpoints for colorectal cancer. Issues identified in
the workshop will be further discussed before the Oncologic Drugs
Advisory Committee (ODAC) and thereafter will be detailed in FDA
Guidance Documents.
DATE: November 12, 2003,
from 8:00 a.m. to 5:00 p.m.
ADDRESS: Marriott Wardman
Park Hotel, 2660 Woodley Road, NW, Washington, DC 20008. Marriott
Ballroom Salon 1 . (Phone:
202/328-2000; Metro: Woodley Park – Zoo station on the red line).
REGISTRATION: No
registration is required to attend the meeting. Seating will
be available for 150 people on a first-come, first-served basis.
FOR FURTHER INFORMATION
CONTACT:
Dianne Spillman, Division of Oncology Drug Products
(HFD-150), Center for Drug Evaluation and Research, Food and Drug
Administration, 5600 Fishers Lane, Rockville, MD 20857. Phone:
301-594-5746. Email: spillmand@cder.fda.gov
 Back
to Top 
Back to Cancer Drug Approval Endpoints
Date created: October 14, 2003, Updated: November 7, 2003 |
|
